Startup News 4 years ago
startup #medtech

The Dropout - How Theranos drama shocked the tech and healthcare sectors

TV series that chronicles Theranos founder Elizabeth Holmes' attempt to revolutionize the healthcare industry after dropping out of college and starting a technology company.

Money. Romance. Tragedy. Deception. Hulu’s limited series “The Dropout,” the story of Elizabeth Holmes (Amanda Seyfried) and Theranos, is an unbelievable tale of ambition and fame gone terribly wrong. How did the world’s youngest self-made female billionaire lose it all in the blink of an eye?

“The Dropout” stars Amanda Seyfried as Elizabeth Holmes and Naveen Andrews as Sunny Balwani. The limited series also includes guest stars Utkarsh Ambudkar, Kate Burton, Michel Gill, LisaGay Hamilton, William H. Macy, Elizabeth Marvel, Laurie Metcalf, Dylan Minnette, Alan Ruck, Sam Waterston, Michaela Watkins and more.

The series is executive produced by showrunner Elizabeth Meriwether, Liz Heldens, Liz Hannah, Katherine Pope, Rebecca Jarvis, Victoria Thompson and Taylor Dunn. Michael Showalter directs multiple episodes and also serves as an executive producer along with his Semi-Formal Productions producing partner Jordana Mollick. The series comes to Hulu from Searchlight Television and 20th Television. This is Searchlight Television’s first production.


Elizabeth Anne Holmes

Theranos

Theranos was an American privately held corporation that was touted as a breakthrough health technology company. Founded in 2003 by 19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $10 billion valuation at its peak in 2013 and 2014.

Elizabeth Holmes

Elizabeth Anne Holmes (born February 3, 1984) is an American former biotechnology entrepreneur convicted of criminal fraud. In 2003, Holmes founded and was the chief executive officer (CEO) of Theranos, a now-defunct health technology company that soared in valuation after the company claimed to have revolutionized blood testing by developing methods that could use surprisingly small volumes of blood, such as from a fingerprick.

WHY YOU SHOULD NOT ACCELERATE TWICE?

WHY YOU SHOULD NOT ACCELERATE TWICE?

defaultuser.png
Startup News
4 years ago
Kevin Mitnick - From Hacker to Cybersecurity Advocate, Remembering a Controversial Legend

Kevin Mitnick - From Hacker to Cybersecurity Advocate, Remembering a C...

defaultuser.png
Startup News
3 years ago
AI Meets Influencer Marketing: Croatian Hypefy lands Seed round led by Fil Rouge Capital

AI Meets Influencer Marketing: Croatian Hypefy lands Seed round led by...

defaultuser.png
Startup News
1 year ago
Daniel Dines, UiPath: "We have a 34% share on the RPA market"

Daniel Dines, UiPath: "We have a 34% share on the RPA market"

defaultuser.png
Startup News
4 years ago
Eleven Ventures is launching the Eleven Alpha early stage startups accelerator

Eleven Ventures is launching the Eleven Alpha early stage startups acc...

defaultuser.png
Startup News
4 years ago